Call for Responsible Research and Innovation (RRI) in Health 2022
September 9, 2022
Multiple myeloma: 14 years of surviving thanks to the 'rescue' of advanced therapies
September 12, 2022After two years of absence due to the COVID-19 pandemic, the Monsoon Women's Race returns on October 9, at 11:00 a.m., to benefit the Aragón Health Research Institute (IIS Aragón), since its proceeds will go to the project 'Born to kill: immune cells recruited for the war against the childhood leukemias'. Its main researcher is Ariel Ramirez, from the Immunotherapy and Cancer Group (I2C) of the IIS Aragón.
The registration period will open next Sunday, September 11, at 12:00 p.m. and will end on September 29 at 12:00 p.m. or when the planned 1.000 places are sold out. It can be done through the web www.carreradelamujermonzon.es, with a cost of 10 euros. Furthermore, in this 6th edition, the contribution for a non-profit association based in Monzón or in the Cinca Medio region will be for AMO Asociación Autismo Zona Oriental de Huesca y otros Tortornos, with one euro for each registration.
The Ciudad de Monzón Women's Race is an initiative that was born with the main objective of achieving the participation of women in physical activity, encouraging them to play sports, enjoy it and gain health through an activity that is motivating and not exclusive, but also as a solidarity project in favor of the fight against cancer in a playful environment as a way to raise the maximum possible funds to develop and enhance scientific research. The first edition was held in 2014, with almost a thousand participants, becoming the largest women's sporting event in the city of Huesca.
Its relationship with IIS Aragón began in 2018, when the organization donated the 10.900 euros raised in that edition to the 'Immune biomarkers for the treatment of metastasis through immunotherapy' project, from the 'Miguel Servet Medical Oncology' research group. Several program leaders then visited the IIS Aragón facilities, where they were able to meet the teams of researcher Julián Pardo, coordinator of the 'Immunity, cancer and diseases of infectious origin or molecular basis' program, and Dr. Antonio Antón, head of the Service. of Oncology at the Miguel Servet Hospital. Following the success of that call, in 2019 the donation amounted to 12.650 euros, an amount that was allocated to the project 'Development of immunotherapy with natural killer (NK) cells for the treatment of childhood brain tumors'.